Amid intensifying competition in the weight-loss drug market, Novo Nordisk's (NVO) early January release of its oral GLP-1 version sparked hope for a...
Humana (HUM) investors may have suffered cardiac arrest yesterday after shares of the health insurer cratered 21% to close below $208 – the lowest...
Swiss oncology powerhouse BeOne Medicines (ONC) has emerged as one of 2025's top performers in a sector often plagued by volatility. Year-to-date,...
Here's Why UnitedHealth Group Is Ready to Soar UnitedHealth Group (UNH) has staged a remarkable recovery from its August lows that followed a brutal...
Oscar Health Surges on Trump Obamacare Pitch: Real Turnaround or Hype? Oscar Health (OSCR) shares are surging 18% in premarket trading this morning...
It looks like the federal government shutdown may be ending, as Senate Republicans and Democrats have reached an agreement to reopen the government...
The largest U.S. health insurer, UnitedHealth Group (UNH), delivered a strong third-quarter performance this morning, underscoring its ongoing...
Cannabis stocks were all the hype in late 2020 to early 2021, before fading away for years, but a similar, but smaller, rally seems to be starting up...
UniQure (QURE) surged over 250% today and almost crossed $50 after the company released Phase 1/2 data for AMT-130, which is its experimental gene...
Novo Nordisk (NVO), the Danish pharmaceutical leader, has reclaimed its dominance in the GLP-1 market, driven by strategic agility and innovative...
Circumstances haven’t been easy for UnitedHealth Group (NYSE:UNH) investors. Earlier this year, the insurance giant tanked due to a convergence of...
Although the broader healthcare sector has witnessed significant turbulence throughout this year, some notable players have been making positive...
Let’s cut to the chase: the only reason why people read financial publication articles is to look for an edge in the market. But with the latest...
Tilray Soars on Marijuana Reclassification Buzz—But the Smoke May Clear Fast Tilray (TLRY) shares are on the move again after renewed momentum...
In the pharmaceutical space, there’s nothing hotter than weight-loss drugs. Seemingly every YouTube video features an advertisement on how...
Vertex Pharmaceuticals (VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically had a strong R&D...
Novo Nordisk (NVO) has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly (LLY) plateaued but...
Straight up, I’m not a big fan of trading securities in the pharmaceutical and biotechnology spaces — essentially, anything can happen (and...
Maybe The Wall Street Journal wasn't so "deeply irresponsible" after all. UnitedHealth Group (UNH), the nation’s largest health insurer, has...
Due to their high-entropy nature, I’m not the biggest fan of specialized healthcare enterprises. With Exact Sciences (NASDAQ:EXAS) straddling the...